Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
作者信息
Maggioni A P, Franzosi M G, Malacrida R, Tognoni G
机构信息
Istituto di Ricerche Farmacologiche M. Negri, Milan, Italy.
出版信息
Clin Cardiol. 1991 Jul;14(7):549-56.
PMID:1747963
Abstract
摘要
相似文献
1
Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
Clin Cardiol. 1991 Jul;14(7):549-56.
2
Thrombolytic therapy for myocardial infarction.
Md Med J. 1990 Apr;39(4):377-81.
3
What you should know about thrombolytic therapy for acute MI.关于急性心肌梗死溶栓治疗你应该了解的内容。
Am J Nurs. 1993 Sep;93(9):24-31; quiz 33.
4
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.GISSI-2：一项针对12490例急性心肌梗死患者进行的阿替普酶与链激酶、肝素与无肝素对比的析因随机试验。意大利心肌梗死存活研究组。
Lancet. 1990 Jul 14;336(8707):65-71.
5
Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
Clin Cardiol. 1991 Jul;14(7):548.
6
[t-PA in thrombolytic therapy of acute myocardial infarct].[组织型纤溶酶原激活剂在急性心肌梗死溶栓治疗中的应用]
Herz. 1994 Dec;19(6):336-52.
7
[Canadian Consensus Conference on Coronary Thrombolysis--current aspects].[加拿大冠状动脉溶栓共识会议——当前情况]
Can J Cardiol. 1995 Jul-Aug;11(7):581-6.
8
[Tissue plasminogen activator is the best thrombolytic agent].
Arq Bras Cardiol. 1994 Jul;63(1):57-8.
9
Thrombolytic therapy in acute myocardial infarction: an emergency department perspective.急性心肌梗死的溶栓治疗：急诊科视角
Henry Ford Hosp Med J. 1991;39(3-4):184-94.
10
Early patency in acute myocardial infarction.
Can J Cardiol. 1993 Mar;9(2):149-51.
Zotero 插件